Imax price target raised to $32 from $28 at Barrington

Barrington raised the firm’s price target on Imax (IMAX) to $32 from $28 and keeps an Outperform rating on the shares following the Q4 report. The consumer preference for a premium large format experience should continue to benefit Imax at the box office, and the leverage in its business model should support margin expansion, the analyst tells investors in a research note.